<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01478867</url>
  </required_header>
  <id_info>
    <org_study_id>CELIQK2</org_study_id>
    <nct_id>NCT01478867</nct_id>
  </id_info>
  <brief_title>Detection of Immunotoxic Gluten Peptides in Feces</brief_title>
  <acronym>CELIQK2</acronym>
  <official_title>Phase 0 Monitoring of Gluten-free Diet Compliance in Celiac Patients by Assessment of Gliadin 33-mer Equivalent Epitopes in Feces</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Seville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto Hispalense de Pediatría, Seville, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Seville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to monitor of gluten-free diet compliance in celiac patients by
      assessment of gliadin 33-mer equivalent epitopes in feces.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Certain immunotoxic peptides from gluten are resistant to gastrointestinal digestion and can
      interact with celiac patient factors to trigger immunological response. Gluten-free diet
      (GFD) is the only effective treatment for celiac disease (CD) and its compliance should be
      monitored to avoid accumulative damage. However, practical methods to monitor diet compliance
      and to detect the origin of an outbreak of celiac clinical symptoms are not available.

      This study assesses the capacity to determine the gluten ingestion, and to monitor the GFD
      compliance in celiac patients by detection of gluten and gliadin 33-mer equivalent peptidic
      epitopes in human feces.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Monitoring of gluten-free diet compliance in celiac patients</measure>
    <time_frame>April-July 2011 (3 months)</time_frame>
    <description>Usual gluten diet for celiac (home diet not modified for this trial)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">53</enrollment>
  <condition>Celiac Disease</condition>
  <arm_group>
    <arm_group_label>Celiac patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Detection of gluten in feces</intervention_name>
    <description>Detection of Gluten in Feces</description>
    <arm_group_label>Celiac patients</arm_group_label>
    <other_name>Gluten-free diet</other_name>
    <other_name>Celiac patients</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Fecal samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Celiac patients, 1-12 years old
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Celiac patient

          -  1-12 years old

          -  Written informed consent

        Exclusion Criteria:

          -  Known inflammatory bowel diseases

          -  Participation in any other studies involving investigational concomitantly or within
             two weeks prior to entry into the study and during the course of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carolina Sousa, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Seville, Spain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Microbiology and Parasitology, Faculty of Pharmacy, University of Seville</name>
      <address>
        <city>Seville</city>
        <zip>41012</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Morón B, Cebolla A, Manyani H, Alvarez-Maqueda M, Megías M, Thomas Mdel C, López MC, Sousa C. Sensitive detection of cereal fractions that are toxic to celiac disease patients by using monoclonal antibodies to a main immunogenic wheat peptide. Am J Clin Nutr. 2008 Feb;87(2):405-14.</citation>
    <PMID>18258632</PMID>
  </reference>
  <reference>
    <citation>Morón B, Bethune MT, Comino I, Manyani H, Ferragud M, López MC, Cebolla A, Khosla C, Sousa C. Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide. PLoS One. 2008 May 28;3(5):e2294. doi: 10.1371/journal.pone.0002294.</citation>
    <PMID>18509534</PMID>
  </reference>
  <reference>
    <citation>Hausch F, Shan L, Santiago NA, Gray GM, Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol. 2002 Oct;283(4):G996-G1003.</citation>
    <PMID>12223360</PMID>
  </reference>
  <reference>
    <citation>Shan L, Molberg Ø, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C. Structural basis for gluten intolerance in celiac sprue. Science. 2002 Sep 27;297(5590):2275-9.</citation>
    <PMID>12351792</PMID>
  </reference>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2011</study_first_submitted>
  <study_first_submitted_qc>November 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2011</study_first_posted>
  <last_update_submitted>November 23, 2011</last_update_submitted>
  <last_update_submitted_qc>November 23, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Seville</investigator_affiliation>
    <investigator_full_name>Carolina Sousa Martin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>celiac disease</keyword>
  <keyword>gluten-free diet</keyword>
  <keyword>gluten peptides</keyword>
  <keyword>feces</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celiac Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

